Center for Scientific Review; Notice of Closed Meeting, 14546 [2022-05469]
Download as PDF
<![CDATA[
14546
Federal Register / Vol. 87, No. 50 / Tuesday, March 15, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Number
of respondents
Number of
responses per
respondent
795
1
795
Life Scientists ...................................................................................................
Dated: March 9, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director,National
Institutes of Health.
Dated: March 10, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–05474 Filed 3–14–22; 8:45 am]
[FR Doc. 2022–05469 Filed 3–14–22; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Substance Abuse and Mental Health
Services Administration
Center for Scientific Review; Notice of
Closed Meeting
Fiscal Year (FY) 2022 Notice of
Funding Opportunity (NOFO)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
AGENCY:
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neuroimaging Technologies.
Date: April 13, 2022.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sharon S. Low, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5104,
MSC 7846, Bethesda, MD 20892, 301–237–
1487, lowss@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Sep<11>2014
21:10 Mar 14, 2022
Jkt 256001
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award
supplemental funding to the Certified
Community Behavioral Health Clinic
(CCBHC) Expansion (Short Title:
CCBHC Expansion Grants) NOFO SM–
20–012 grant recipients funded in FY
2020.
This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) is supporting administrative
supplements (in scope of the parent
award) up to $249,999 (total costs) for
the 166 CCBHC Expansion grant
recipients funded in FY 2020 under the
Certified Community Behavioral Health
Clinic (CCBHC) Expansion (Title:
CCBHC Expansion Grants, NOFO SM–
20–012, with a project end date of April
30, 2022) to cover unanticipated costs
caused by the COVID–19 pandemic or
related mitigation efforts that could not
have been covered by rebudgeting
existing funds. The supplemental
funding is to assist CCBHC Expansion
grant recipients that had unplanned
administrative, staffing, labor, and other
program costs due to the COVID–19
pandemic.
FOR FURTHER INFORMATION CONTACT:
Mary Blake, Substance Abuse and
Mental Health Services Administration,
5600 Fishers Lane, Rockville, MD
20857, telephone (240) 276–1747; email:
mary.blake@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION: It is
expected that recipients of this
supplemental funding will provide
services and supports consistent with
SUMMARY:
PO 00000
Frm 00107
Fmt 4703
Sfmt 4703
Average
burden per
response
(in hours)
Total annual
burden hour
90/60
........................
1193
1193
the approved activities in the FY 2020
CCBHC Expansion Grants NOFO SM–
20–012 and the majority of funds will be
used for services. No more than 15
percent of these funds may be used for
infrastructure, supplies, or equipment.
SAMHSA expects that this program will
improve the behavioral health of
individuals across the nation by
providing comprehensive communitybased mental and substance use
disorder services; treatment of cooccurring disorders; advance the
integration of behavioral health with
physical health care; assimilate and
utilize evidence-based practices on a
more consistent basis; and promote
improved access to high quality care.
Supplemental awards will be
prioritized for FY 2020 CCBHC
Expansion grant recipients with an
unobligated balance of less than
$1,000,000 under their current grant.
This is not a formal request for
application. Assistance will only be
provided to the 166 CCBHC Expansion
grant recipients, funded in FY 2020
under NOFO SM–20–012, based on the
receipt of a satisfactory application and
associated budget that is approved by a
review group.
Funding Opportunity Title: FY 2020
CCBHC Expansion Supplemental
Funding.
Assistance Listing Number: 93.696.
Authority: Section 520A (42 U.S.C.
290bb–32) of the Public Health Service
Act, as amended.
Justification: Eligibility for this
supplemental funding is limited to the
166 CCBHC Expansion grant recipients
who received funding in FY 2020 under
the CCBHC Expansion Grants NOFO
SM–20–012. These recipients have
experienced unexpected and/or
increased costs for program activities
and services due to the COVID–19
pandemic. It is expected that this
supplemental funding will allow
CCBHC Expansion grant recipients to
provide the required and approved
program activities and services that
were affected during the pandemic.
Carlos Graham,
Reports Clearance Officer.
[FR Doc. 2022–05399 Filed 3–14–22; 8:45 am]
BILLING CODE 4162–20–P
E:\FR\FM\15MRN1.SGM
15MRN1
]]>Agencies
[Federal Register Volume 87, Number 50 (Tuesday, March 15, 2022)]
[Notices]
[Page 14546]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05469]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Neuroimaging Technologies.
Date: April 13, 2022.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sharon S. Low, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5104, MSC 7846, Bethesda, MD 20892, 301-237-
1487, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: March 10, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-05469 Filed 3-14-22; 8:45 am]
BILLING CODE 4140-01-P
